Member area login
You don't have or don't remember the password!
Click Here
Maria Stella Graziani

Deputy Director
Martina Zaninotto

Associate Editors
Ferruccio Ceriotti
Davide Giavarina
Bruna Lo Sasso
Giampaolo Merlini
Martina Montagnana
Andrea Mosca
Paola Pezzati
Rossella Tomaiuolo
Matteo Vidali

EIC Assistant
Francesco Busardò

International Advisory Board Khosrow Adeli Canada
Sergio Bernardini Italy
Marcello Ciaccio Italy
Eleftherios Diamandis Canada
Philippe Gillery France
Kjell Grankvist Sweden
Hans Jacobs The Netherlands
Eric Kilpatrick UK
Magdalena Krintus Poland
Giuseppe Lippi Italy
Mario Plebani Italy
Sverre Sandberg Norway
Ana-Maria Simundic Croatia
Tommaso Trenti Italy
Cas Weykamp The Netherlands
Maria Willrich USA
Paul Yip Canada

Biomedia srl
Via L. Temolo 4, 20126 Milano

Responsible Editor
Giuseppe Agosta

Editorial Secretary
Chiara Riva
Biomedia srl
Via L. Temolo 4, 20126 Milano
Tel. 0245498282


ISSN print: 0393 – 0564
ISSN digital: 0392- 7091

BC: Articoli scritti da U. Russo

Determinazione dell’omocisteina plasmatica: indicazioni per la richiesta
Determination of plasma homocysteine: recommendations for test requesting
D. Szőke  |  A. Dolci  |  U. Russo  |  M. Panteghini  | 
<p>High plasma homocysteine&nbsp;concentrations can be caused by various factors, including low blood concentrations of B-complex vitamins.&nbsp;Hyperhomocysteinemia is widely believed to be associated with an increased risk of atherosclerotic disease; recent&nbsp;emerging evidence made, however, doubtful its role as cardiovascular risk factor. The aim of this document was to&nbsp;examine the appropriateness of homocysteine requesting in our clinical setting. Clinical guidelines, meta-analyses&nbsp;and systematic reviews were used as source of high level evidence. During the last two decades, the role of&nbsp;hyperhomocysteinemia was examined in a number of clinical conditions; however, the analysis of available data&nbsp;made us clear that determination of plasma homocysteine has only limited clinical role. Test requesting results to be&nbsp;appropriate only in case of suspected homocystinuria (an inherited disorder of the metabolism of the amino acid&nbsp;methionine), in patients with previous venous or arterial thromboembolism and in patients with severe (&gt;100 &mu;mol/L)&nbsp;[and possibly moderate (&gt;30 &mu;mol/L)] hyperhomocysteinemia treated with B-complex vitamins. Determination of&nbsp;plasma homocysteine is not recommended as a primary prevention tool for cardiovascular disease in the general&nbsp;population.</p>
Biochimica Clinica ; 38(3) 234-237
Documenti - Documents